Thu. 9 May 2024, 4:18pm ET
Benzinga
Earnings, Earnings Misses, News
Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.21) by 47.62 percent. This is a 55 percent decrease over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $467.854 thousand which missed the analyst consensus estimate of $3.050 million by 84.66 percent. This is a 22.28 percent decrease over sales of $601.957 thousand the same period last year.